Founded with a vision to

TRANSFORM

We began as a vision in our CEO’s small New York City apartment. Now we’re a biotech firm that’s nearly 600 people strong. Since 2002, we’ve pioneered a novel scientific platform to answer critical needs in the liver health community.

The Intercept Story

Our story dates back nearly 40 years. The company started as a vision in our CEO’s small New York City apartment and we’ve grown into a biotech firm that is nearly 600 people strong, with one approved product and additional investigational therapies currently in development.

Leadership

Our executive leadership taps into an expertise in liver health and strong business acumen.

Mark Pruzanski, M.D.
Chief Executive Officer
& President

BOARD OF DIRECTORS

Our board members help drive our vision further.

MEET THEM

LOCATIONS

Our worldwide headquarters are located in communities where revitalization is underway.

SEE ALL

GL-NP-N/A-0093